Literature DB >> 17159241

Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma.

Eijiro Nakamura1, William G Kaelin.   

Abstract

Pheochromocytomas and paragangliomas are rare tumors derived from chromaffin cells. These tumors can arise in the context of hereditary cancer syndromes such as von Hippel- Lindau disease, multiple endocrine neoplasia type 2, and neurofibromatosis 1. Recent studies indicate that germ line mutations of genes encoding specific succinate dehydrogenase (SDH) subunits also predispose individuals to pheochromocytomas and paragangliomas. This review focuses on the genetics of these tumors and suggests a possible link between familial pheochromocytomas/paraganglioma genes and control of neuronal apoptosis during embryological development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159241     DOI: 10.1385/ep:17:2:97

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  60 in total

Review 1.  Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease.

Authors:  C Eng
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

2.  Direct interaction of the beta-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes.

Authors:  H Okuda; S Hirai; Y Takaki; M Kamada; M Baba; N Sakai; T Kishida; S Kaneko; M Yao; S Ohno; T Shuin
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

3.  Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.

Authors:  R M Hofstra; T Stelwagen; R P Stulp; D de Jong; M Hulsbeek; E J Kamsteeg; A van den Berg; R M Landsvater; A Vermey; W M Molenaar; C J Lips; C H Buys
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

Review 4.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

5.  Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells.

Authors:  A Kieser; T Seitz; H S Adler; P Coffer; E Kremmer; P Crespo; J S Gutkind; D W Henderson; J F Mushinski; W Kolch; H Mischak
Journal:  Genes Dev       Date:  1996-06-15       Impact factor: 11.361

6.  Genetic aberrance of sporadic MEN 2A component tumours: analysis of RET.

Authors:  Nam Hoon Cho; Hyun Woo Lee; Shin Young Lim; Suki Kang; Wung Yun Jung; Chung Su Park
Journal:  Pathology       Date:  2005-02       Impact factor: 5.306

7.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors:  H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

Review 8.  Molecular basis of the VHL hereditary cancer syndrome.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

9.  Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.

Authors:  Michael Zimmer; Darrell Doucette; Naila Siddiqui; Othon Iliopoulos
Journal:  Mol Cancer Res       Date:  2004-02       Impact factor: 5.852

10.  Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis.

Authors:  S Estus; W J Zaks; R S Freeman; M Gruda; R Bravo; E M Johnson
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  8 in total

Review 1.  Review: the role of neural crest cells in the endocrine system.

Authors:  Meghan Sara Adams; Marianne Bronner-Fraser
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 2.  Pheochromocytomas and paragangliomas: assessment of malignant potential.

Authors:  Tim I M Korevaar; Ashley B Grossman
Journal:  Endocrine       Date:  2011-10-25       Impact factor: 3.633

Review 3.  Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.

Authors:  Svenja Nölting; Ashley B Grossman
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

4.  An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

Authors:  Francien H van Nederveen; José Gaal; Judith Favier; Esther Korpershoek; Rogier A Oldenburg; Elly M C A de Bruyn; Hein F B M Sleddens; Pieter Derkx; Julie Rivière; Hilde Dannenberg; Bart-Jeroen Petri; Paul Komminoth; Karel Pacak; Wim C J Hop; Patrick J Pollard; Massimo Mannelli; Jean-Pierre Bayley; Aurel Perren; Stephan Niemann; Albert A Verhofstad; Adriaan P de Bruïne; Eamonn R Maher; Frédérique Tissier; Tchao Méatchi; Cécile Badoual; Jérôme Bertherat; Laurence Amar; Despoina Alataki; Eric Van Marck; Francesco Ferrau; Jerney François; Wouter W de Herder; Mark-Paul F M Vrancken Peeters; Anne van Linge; Jacques W M Lenders; Anne-Paule Gimenez-Roqueplo; Ronald R de Krijger; Winand N M Dinjens
Journal:  Lancet Oncol       Date:  2009-07-01       Impact factor: 41.316

5.  The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.

Authors:  Susanne Schlisio; Rajappa S Kenchappa; Liesbeth C W Vredeveld; Rani E George; Rodney Stewart; Heidi Greulich; Kristina Shahriari; Nguyen V Nguyen; Pascal Pigny; Patricia L Dahia; Scott L Pomeroy; John M Maris; A Thomas Look; Matthew Meyerson; Daniel S Peeper; Bruce D Carter; William G Kaelin
Journal:  Genes Dev       Date:  2008-03-11       Impact factor: 11.361

Review 6.  Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.

Authors:  W G Kaelin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-11-16

7.  A conditional mouse mutant in the tumor suppressor SdhD gene unveils a link between p21(WAF1/Cip1) induction and mitochondrial dysfunction.

Authors:  Africa Millán-Uclés; Blanca Díaz-Castro; Paula García-Flores; Alicia Báez; José Antonio Pérez-Simón; José López-Barneo; José I Piruat
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

8.  XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosis.

Authors:  Zhang'e Choo; Rachel Yu Lin Koh; Karin Wallis; Timothy Jia Wei Koh; Chik Hong Kuick; Veronica Sobrado; Rajappa S Kenchappa; Amos Hong Pheng Loh; Shui Yen Soh; Susanne Schlisio; Kenneth Tou En Chang; Zhi Xiong Chen
Journal:  Oncotarget       Date:  2016-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.